TAPB Combined With RSB Versus ESPB for Postoperative Analgesia After Laparoscopic Liver Resection
Transversus Abdominis Plane Block Combined With Rectus Sheath Block Versus Erector Spinae Plane Block for Postoperative Analgesia After Laparoscopic Liver Resection
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Estimated)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Contact
Study Contact
- Name: Yi Zhang, Dr.
- Phone Number: 13986039131
- Email: doc_zhang18@163.com
Study Contact Backup
- Name: Mengke Liu
- Phone Number: 15516722009
- Email: Lmk2268939177@163.com
Study Locations
-
-
Hubei
-
WuHan, Hubei, China, 430030
- Tongji Hospital, Tongji Medical College, Huazhong University of Science & Technology
-
Contact:
- Yi Zhang, Dr.
- Phone Number: 13986039131
- Email: doc_zhang18@163.com
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- ASA grades I-II;
- Age 18~70 years old;
- BMI 19~28kg/m2;
- Patients undergoing elective laparoscopic partial liver resection;
Exclusion Criteria:
- The nerve block cannot be performed, such as skin infection at the puncture site;
- Daily using the opioid analgesics or have a history of opioid abuse;
- Allergy or a history of drug allergy to any of the drugs used in the study;
- Patients have cognitive impairment, mental or neurological diseases, motor or sensory deficits;
- Coagulation disorders;
- Severe lung, heart, liver, or kidney dysfunction;
- Participating in other clinical trials within 3 months before being included in this study;
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Quadruple
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: ESPB
erector spinae plane block
|
The experimental group received ultrasound-guided erector spinae plane block, and bilateral erector spinae plane block was performed at T7 segment with 20ml 0.375% ropivacaine on each side.While the control group received ultrasound-guided transversus abdominis plane block combined with rectus sheath block, which will be performed under the costal margin with 10ml 0.375% ropivacaine for bilateral transversus abdominis plane block and 10ml 0.375% ropivacaine for bilateral rectus sheath block.
Other Names:
|
|
Active Comparator: TAPB&RSB
transversus abdominis plane block combined with rectus sheath block
|
The experimental group received ultrasound-guided erector spinae plane block, and bilateral erector spinae plane block was performed at T7 segment with 20ml 0.375% ropivacaine on each side.While the control group received ultrasound-guided transversus abdominis plane block combined with rectus sheath block, which will be performed under the costal margin with 10ml 0.375% ropivacaine for bilateral transversus abdominis plane block and 10ml 0.375% ropivacaine for bilateral rectus sheath block.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The dose of morphine used
Time Frame: 24 hours after surgery
|
dosage of analgesic pump
|
24 hours after surgery
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The dose of morphine used
Time Frame: 1hour, 2hours, 4hours and 8hours after surgery
|
dosage of analgesic pump
|
1hour, 2hours, 4hours and 8hours after surgery
|
|
The number of rescue analgesia
Time Frame: 1hour, 2hours, 4hours, 8hours and 24hours after surgery
|
times of rescue analgesia
|
1hour, 2hours, 4hours, 8hours and 24hours after surgery
|
|
Visual analogue scale scores in resting and coughing state
Time Frame: 1hour, 2hours, 4hours, 8hours and 24hours after surgery
|
Visual analogue scale (VAS): a 100 mm transverse line with 0mm at one end of the line indicates no pain, 100mm at the other end indicates severe pain and the middle part shows different levels of pain.
|
1hour, 2hours, 4hours, 8hours and 24hours after surgery
|
|
The value of central venous pressure
Time Frame: 5min, 10min, 15min and 30min after nerve block
|
ultrasound-guided internal jugular vein catheterization connected with transducer
|
5min, 10min, 15min and 30min after nerve block
|
|
QoR-15 scores
Time Frame: before and 24h after surgery
|
The QOR-15 scale was scored from 0 (very poor QoR) to 150 (excellent QoR).
A higher score indicates a better patient status.
|
before and 24h after surgery
|
|
Quantitative assessment of liver function
Time Frame: before and 1days, 3days after surgery
|
The levels of plasma liver function markers AST and ALT before and after liver resection.
|
before and 1days, 3days after surgery
|
|
Postoperative Complications
Time Frame: 2hours, 4hours, 8hours and 24hours after surgery
|
Including nausea, vomiting, pruritus, dizziness, headache, constipation, urinary retention, respiratory depression and so on.
|
2hours, 4hours, 8hours and 24hours after surgery
|
|
Recovery time nodes
Time Frame: follow up patients for an average of half a month
|
drainage tube removal time, offbed activity, or postoperative hospital stay, etc.
|
follow up patients for an average of half a month
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start (Estimated)
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
Other Study ID Numbers
- TJ-IRB20230951
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.